BETA
Start SIP
Invest Now
Start SIP in BETA
Beta Drugs live price: ₹1189.3. It opened at ₹1,101 vs previous close ₹1,165; intraday high/low: ₹1,224/₹1,101. The 50 & 200 DMA stand at ₹1,236.73/₹1,523.12.
Beta Drugs Performance
- Today's Low
- ₹1,101
- Today's High
- ₹1,224
- 52 Week Low
- ₹990
- 52 Week High
- ₹2,000
- Open Price₹1,101
- Previous Close₹1,165
- Volume55,019
- 50 DMA₹1,236.73
- 100 DMA₹1,384.40
- 200 DMA₹1,523.12
Investment Returns
- Over 1 Month + 13.09%
- Over 3 Month -21.38%
- Over 6 Month -34.07%
- Over 1 Year -37.59%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29
- PEG Ratio
- -
- Market Cap Cr
- 1,201
- P/B Ratio
- 5.2
- Average True Range
- 81.13
- EPS
- 43.1
- Dividend Yield
- 0
- MACD Signal
- -42.28
- RSI
- 54.27
- MFI
- 51.09
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,189.30
+
24.6
(2.11%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,133.66
- 50 Day
- ₹1,236.73
- 100 Day
- ₹1,384.40
- 200 Day
- ₹1,523.12
Resistance and Support
1171.37
- R3 1,364.53
- R2 1,294.17
- R1 1,241.73
- S1 1,118.93
- S2 1,048.57
- S3 996.13
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2026-01-09 | Others | To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Popular Stocks
TCS Share PriceIRFC Share PriceIREDA Share PriceIRCTC Share PriceITC Share PriceWipro Share PriceSuzlon Share PriceTata Steel Share PriceYes Bank Share PriceHDFC Share PriceTata Power Share PriceInfosys Share PriceTata Motors Share PriceAdani Power Share PriceNHPC Share PriceRVNL Share PriceVedanta Share PricePaytm Share PriceLIC Share PriceBHEL Share Price
Beta Drugs FAQs
Beta Drugs share price is ₹1,189 As on 30 March, 2026 | 19:43
The Market Cap of Beta Drugs is ₹1200.6 Cr As on 30 March, 2026 | 19:43
The P/E ratio of Beta Drugs is 29 As on 30 March, 2026 | 19:43
The PB ratio of Beta Drugs is 5.2 As on 30 March, 2026 | 19:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.